Skip to main content
Journal Guides8 min readUpdated Apr 20, 2026

Journal of Immunology Review Time

Journal of Immunology's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.

Author contextAssociate Professor, Immunology & Infectious Disease. Experience with Immunity, Nature Immunology, Journal of Experimental Medicine.View profile

What to do next

Already submitted to Journal of Immunology? Use this page to interpret the status and choose the next step.

The useful next step is understanding what the status usually means at Journal of Immunology, how long the wait normally runs, and when a follow-up is actually reasonable.

Timeline context

Journal of Immunology review timeline: what the data shows

Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.

Full journal profile
Time to decision~90-120 days medianFirst decision
Acceptance rate~40-50%Overall selectivity
Impact factor3.4Clarivate JCR

What shapes the timeline

  • Desk decisions are fast. Scope problems surface within days.
  • Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
  • Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.

What to do while waiting

  • Track status in the submission portal — status changes signal active review.
  • Wait at least the journal's stated median before sending a status inquiry.
  • Prepare revision materials in parallel if you expect a revise-and-resubmit decision.

Quick answer: Journal of Immunology review time is more transparent than many journals in its band. The journal officially reports an average of 39 days from submission to initial decision for full-length manuscripts. Current author-reported data suggest about 1.9 months for the first review round and around 4.4 months total handling time for accepted manuscripts. That combination makes JI a moderate-speed journal with a reasonably understandable process. The main risk is usually not hidden delay. It is sending a paper that is still too descriptive or insufficiently mechanistic for the journal's editorial taste (per SciRev community data and JCR latest release).

Journal of Immunology metrics at a glance

Metric
Current value
What it means for authors
Submission to initial decision
39 days
The journal publishes a concrete front-end timing number
First review round
About 1.9 months in current author-reported data
Reviewed manuscripts often land in the 5 to 8 week range
Total handling time for accepted papers
About 4.4 months in current author-reported data
The overall path is substantial but not unusually long
Impact Factor (JCR 2024)
3.4
Citation prestige is lower than many authors expect
5-year Journal Impact Factor
3.9
Longer-tail influence slightly exceeds the 2-year number
CiteScore (2024)
7.2
Scopus view is somewhat stronger than JCR alone suggests
Acceptance rate
50% for full-length articles; 67% for Cutting Edge (2023)
The journal is selective but not brutally rarefied
Main fit test
Novel experimental immunology with functional depth
Descriptive immunophenotyping struggles

The useful thing here is that the journal gives you enough information to plan honestly. It is not especially fast, but it is not an opaque black box either.

What the official numbers do and do not tell you

The Journal of Immunology's Oxford Academic page is unusually helpful for a field journal because it publishes:

  • the current impact metrics
  • a concrete average time to initial decision
  • the current acceptance rates by article type

That tells you:

  • the journal is not hiding its turnaround profile
  • initial editorial movement is usually visible inside about five to six weeks
  • the journal is not operating like a low-acceptance prestige lottery

It does not tell you:

  • how much of the delay comes from papers that are mechanistically thin
  • how much longer a manuscript takes when reviewers ask for functional reinforcement
  • whether the paper is really a JI article or a better match for ImmunoHorizons, JCI, or a disease journal

That gap matters because JI timing is mostly predictable. The harder problem is editorial fit around mechanistic depth.

A practical timeline authors can actually plan around

Stage
Practical expectation
What is happening
Initial editorial screening
About 2 to 4 weeks
Editors assess novelty, section fit, and whether the paper is mechanistic enough
Initial decision
Around the 39-day official average
This may be send-out, rejection, or a request shaped by editorial fit
Peer review
Roughly 5 to 8 weeks for many reviewed papers
Current author-reported data average out to about 1.9 months
Revision cycle
Several weeks to a few months
Functional validation often drives the size of the revision
Acceptance
Around 4.4 months total in current author-reported data
Good-fit papers can move steadily through the process

That is a realistic working model: moderate front-end speed, moderate review speed, and a total path that remains manageable when the manuscript already fits the journal well.

Why the Journal of Immunology often feels moderate at the desk

JI is not a same-week triage machine, but it is also not a journal that lets clearly mismatched work drift forever. Editors are practicing scientists, and the journal has a fairly stable idea of what belongs.

Papers tend to get filtered when they are:

  • descriptive immunophenotyping without enough function
  • disease papers where the immunology is secondary
  • reagent or epitope papers without deeper mechanistic consequence
  • systems or omics studies that stop before biological interpretation becomes concrete
  • manuscripts that would more naturally live in ImmunoHorizons or a narrower journal

That is why the 39-day number is useful. It usually reflects a real editorial read rather than a superficial pass.

What usually slows the Journal of Immunology down

The slower cases are usually not the obviously wrong ones. They are the ones where the paper is real immunology but still one layer short of editorial confidence.

The common causes are:

  • reviewer demands for stronger functional validation
  • questions about physiological relevance
  • manuscripts that identify an immune pattern but do not yet explain the mechanism convincingly
  • revision rounds where more data arrive but the main immunological point remains only partly resolved
  • borderline section fit, especially between JI and softer or more translational alternatives

When JI feels slow, it is often because the manuscript is being asked to become more mechanistically decisive.

Journal of Immunology citation metric trend and what it means for review time

For year-over-year impact factor data, see the journal of immunology citation metric page.

The Journal of Immunology is down from 3.6 in 2023 to 3.4 in 2024, continuing the longer decline from its earlier society-journal position.

For review time, the useful implication is not that the journal became slow or weak. It is that authors increasingly use the journal strategically rather than automatically. That makes fit judgment more important than masthead nostalgia.

How the Journal of Immunology compares with nearby journals on timing

Journal
Timing signal
Editorial posture
Journal of Immunology
Moderate and fairly transparent
Mechanistic experimental immunology
ImmunoHorizons
Softer lane for observations and less complete mechanisms
Better for descriptive or early-stage work
Immunity
Much higher prestige bar
Stronger novelty and broader field consequence required
Journal of Experimental Medicine
Higher mechanistic and disease-facing prestige
Better for stronger disease-mechanism stories
Frontiers in Immunology
Often faster and more accessible
Different quality signal and editorial culture

This matters because many JI timing frustrations are really target-choice frustrations. The paper may be sound. It may simply belong in a different immunology lane.

What review-time data hides

Even a relatively transparent journal still leaves some things implicit:

  • the 39-day figure mixes papers with different editorial pathways
  • reviewer delay is often less important than mechanism depth
  • accepted-paper timing depends heavily on whether the revision asks for function, not just text
  • the journal's best use case is still solid experimental immunology with a real mechanistic spine

So the timing data help, but the fit question still governs the experience.

Readiness check

While you wait on Journal of Immunology, scan your next manuscript.

The scan takes about 1-2 minutes. Use the result to decide whether to revise before the decision comes back.

Check my next manuscriptAnthropic Privacy Partner. Zero-retention manuscript processing.Open status guideOr verify a citation in 10 seconds

In our pre-submission review work with Journal of Immunology manuscripts

In our pre-submission review work, the biggest timing mistake is assuming JI will absorb descriptive immunology because it is a society journal with a lower impact factor.

That assumption is wrong surprisingly often.

The papers that move best here usually have:

  • a clear immunological question visible early
  • functional data that support the mechanism instead of just the phenotype
  • enough physiological relevance that the result feels biologically real
  • a manuscript shape that reads like completed experimental immunology, not a first pass

Those traits make the journal's moderate timeline feel efficient instead of frustrating.

What do pre-submission reviews reveal about The Journal of Immunology (American Association of Immunologists) review delays?

In our pre-submission review work on Journal of Immunology-targeted manuscripts, three patterns most consistently predict slow review at The Journal of Immunology (American Association of Immunologists). Of manuscripts we screened in 2025 targeting Journal of Immunology and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: Journal of Immunology reviewers expect both mechanistic depth and explicit cross-immunological-system framing.

Scope-fit ambiguity in the abstract. Journal of Immunology editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (immunology research). The named failure pattern: single-immune-system mechanistic claims without cross-system validation extend revision rounds. Check whether your abstract reads to Journal of Immunology's scope →

Methods package incomplete for the journal's reviewer pool. Journal of Immunology reviewers expect specific methodological detail. Preliminary mechanism claims without orthogonal validation extend reviewer consultation. Check if your methods package is reviewer-complete →

Reference-list and clean-citation failure mode. Editorial team at The Journal of Immunology (American Association of Immunologists) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch →

Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: https://www.jimmunol.org. Manuscript constraints: 350-word abstract limit and 9,000-word main-text cap (Journal of Immunology enforces during desk-screen). We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.

Manusights submission-corpus signal for The Journal of Immunology (American Association of Immunologists). Of the manuscripts our team screened before submission to Journal of Immunology and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is Journal Of Immunology reviewers expect both mechanistic depth and explicit cross-immunological-system framing. In our analysis of anonymized Journal of Immunology-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear Journal of Immunology's scope-fit threshold within the first week and those that get extended editorial-board consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.

Submit If

  • The headline finding fits The Journal of Immunology (American Association of Immunologists)'s editorial scope (immunology research) and the abstract names that fit within the first 100 words for Journal of Immunology's editorial-team triage.
  • The methods section is detailed enough for Journal of Immunology reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text rather than deferred to supplementary materials.
  • The reference list is clean of recently retracted citations.
  • A figure or table makes the contribution visible without specialist translation; the cover letter explicitly names the Journal of Immunology-relevant audience the work is aimed at.

Think Twice If

  • Single-immune-system mechanistic claims without cross-system validation extend revision rounds; this is the named Journal of Immunology desk-screen failure mode our team flags before submission.
  • The cover letter spends a paragraph on background before the new finding appears in the abstract; Journal of Immunology's editorial culture treats this as a scope-fit warning.
  • The reference list cites a paper that has since been retracted without acknowledging the retraction notice.
  • The protocol or methodology section relies on more than 3 figures of supplementary material that should be in the main text for Journal of Immunology's reviewer pool.

What should drive the submission decision instead

For JI, timing matters less than mechanistic sufficiency. The right question is whether the manuscript already behaves like a function-first immunology paper.

That is why the better next reads are:

A Journal of Immunology fit check is usually more useful than worrying about whether 39 days is too slow.

Practical verdict

Journal of Immunology review time is moderate, fairly transparent, and workable for papers that actually fit the journal. The official initial-decision number is useful. The author-reported accepted-paper timeline is also believable. If the manuscript has enough mechanism and function, the process is manageable. If not, the time loss usually comes from trying to make a softer paper clear a harder mechanistic bar.

The Manusights Journal of Immunology readiness scan. This guide tells you what The Journal of Immunology (American Association of Immunologists)'s editors look for in the first 1-2 weeks of triage. The review tells you whether YOUR paper passes that check before you submit. We have reviewed manuscripts targeting The Journal of Immunology (American Association of Immunologists) and peer venues; the named patterns below are the same ones the journal's handling editors and outside reviewers flag at the desk-screen and first-review stages. documented review timeline of approximately 7-10 days for desk-screen. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.

Frequently asked questions

The Journal of Immunology officially reports an average of 39 days from submission to initial decision for full-length manuscripts, based on its current Oxford Academic journal-facts page.

Current author-reported data point to about 1.9 months for the first review round. In practice, that aligns with a first substantive reviewer decision in roughly 5 to 8 weeks for many reviewed manuscripts.

Current author-reported data show about 4.4 months total handling time for accepted manuscripts. That is a useful planning number for papers that are already a good fit for JI.

Mechanistic and functional depth matter most. Descriptive immunology or papers that are better suited to ImmunoHorizons or a disease-specific journal often lose time because the fit is weaker than authors think.

References

Sources

  1. The Journal of Immunology - AAI
  2. 1. The Journal of Immunology about page, Oxford Academic.
  3. 2. The Journal of Immunology author guidelines, Oxford Academic.
  4. 3. Journal of Immunology SciRev journal page, SciRev.
  5. 4. Journal of Immunology impact history, BioxBio.

Best next step

Use this page to interpret the status and choose the next sensible move.

For Journal of Immunology, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.

Guidance first. Use the scan for the next manuscript.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Status Guide